22q11.2 deletion syndrome has a prevalence of approximately 1 in 5000. It is a contiguous gene syndrome caused by a 1.5 to 3.0 Mb deletion of 22q11.2. The deletion is also referred to as DiGeorge syndrome, Shprintzen syndrome or velocardiofacial syndrome. Clinical features include developmental delay, outflow tract defects of the heart (including tetralogy of Fallot, truncus arteriosus, and interrupted aortic arch), hypocalcemia arising from parathyroid hypoplasia, and thymic hypoplasia. Facial features include cleft lip and palate, low-set ears, wide set eyes, a small jaw and a small philtrum. The majority of cases arise as a new deletion but in approximately 10% of cases the deletion is inherited from a parent.
We accept referrals from patients with appropriate clinical features for a diagnosis of DiGeorge syndrome or from family members of known affected patients.
Price & reporting times
NHS referrals to this service are paid for where there is an existing specialist commissioning contract for genetic testing. In other cases please contact the laboratory for prices.
|Test||Price (£ ex VAT)||TRT *|
|Prenatal chorionic villus sample||POA||14 cd|
|Prenatal amniotic fluid sample||POA||14 cd|
|Urgent postnatal blood sample||POA||14 cd|
|Routine postnatal blood sample||POA||28 cd|
Postnatal sample requirements: a blood sample taken into EDTA is required for microarray testing (1-2ml neonates, 2-5ml for children/adults). FISH testing requires a blood sample in lithium heparin (1-2ml neonates, 2-5ml for children/adults).
Test validation & quality assurance - information for users
For information on the validation and limitations of microarray testing please refer to the separate microarray page on this website. FISH testing is performed using either the TBX1 FISH probe from Kreatech Diagnostics (www.kreatech.com) or the TUPLE1 FISH probe from Abbott Molecular(www.abbottmolecular.com).
Please see our referral guidelines for more information.
OMIM Number(s) - 188400
Gene(s) - TBX1